Precision through target visibility and tunable design - Orionis ...
2023年11月15日 · Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic …
About Us - Orionis Biosciences
Orionis Biosciences has research facilities in the Boston area (Waltham, Mass., USA) and Ghent (Belgium), and is operated by a world-class team of scientists, entrepreneurs, and a …
Pipeline - Orionis Biosciences
Orionis is evaluating ORB-011 in a Phase 1 open-label dose-escalation study (NCT05947474) for patients with recurrent or refractory solid tumors amenable to medically safe serial biopsies. …
Platforms - Orionis Biosciences
Orionis has developed two transformative technology platforms. While technologically distinct, addressing small and large molecules, they both harness proximity and cooperativity …
Approach in drug discovery - Orionis Biosciences
Orionis Technology Platforms Molecular proximity and cooperativity mechanisms define mode of action of our drug modalities, and guide discovery, design, and engineering of our therapeutic …
News - Orionis Biosciences
2022年11月14日 · Boston, MA & Ghent, Belgium – Orionis Biosciences, a life sciences company pioneering innovation of highly selective and tunable therapeutics for cancer and beyond, …
Orionis Presents at CNN’s Life Itself Conference
2022年10月18日 · Orionis Chief Data Scientist Riccardo Sabatini presented at CNN’s Life Itself 2022 Conference, an event celebrating the minds and ideas at the intersection of health and …
Orionis Biosciences Announces Collaboration with Genentech to …
2023年9月20日 · Orionis will leverage its Allo-Glue™ platform for discovery of small molecule monovalent glues. September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis …
Orionis Biosciences Announces First Patient Dosed in Phase 1 …
2023年11月15日 · Orionis is evaluating ORB-011 in a Phase 1 open-label dose-escalation study (NCT05947474) for patients with recurrent or refractory solid tumors amenable to medically …
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration
2020年3月5日 · Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis. Orionis has developed innovative technologies in …